Digitalisering och kliniska prövningar

Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Globalt uttalande

Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

Fewer visitors but satisfied exhibitors

Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.

Biden utser coronateam – hans rådgivare kritiserar Tegnell

USA:s nya president Joe Biden intar en helt ny hållning i bekämpningen av covid-19 än sin företrädare. Hans rådgivare Andy Slavitt kritiserade nyligen Anders Te...

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

Söker nyckeln till långt liv i släktforskningsdatabas

Googles dotterbolag Calico ska leta efter gener som kan kopplas till långt liv genom Ancestry.com.

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Ny vd på Klaria

Kommer närmast från Oberland Capital.

Nya resultat om immunförsvarets reaktion vid svår covid-19

Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.

Tar in 250 miljoner

- Klinisk utveckling i sen fas kostar mycket pengar och därför väljer vi att noteras just nu, säger Peter Zerhouni, vd på Index Pharmaceuticals som genomför en ...

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Ny metod förutser lovande läkemedel

Enligt en ny studie kan forskningsbolaget Attanas teknik förbättra lyckandegraden för kliniska studier.

Avtalet med Almirall sägs upp

Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.

LEO Pharma - International Clinical Trial Manager

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.